SCHEMBL118742

SCHEMBL118742

Cc1c(-c2cccc(C(F)(F)F)c2)ccc(N)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.47
BRD4 O60885 1/20 0.47
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
AKR1C3 P42330 3/20 0.42
AKR1C2 P52895 3/20 0.42
PARP10 Q53GL7 1/20 0.41
PARP11 Q9NR21 1/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
KDM1A O60341 2/20 0.40
KCNA3 P22001 1/20 0.40
MAOB P27338 1/20 0.40
PRMT3 O60678 1/20 0.40
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
PRMT1 Q99873 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15091673 0.80 TSHR (0.50) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL29281802 0.79 ADORA2A (0.46) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL28308461 0.78 ADORA2A (0.54) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL6498979 0.76 IKBKB (0.48) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL18286700 0.76 AKR1C3 (0.46) IKBKBBRD4ADORA2AADORA1AKR1C3
SCHEMBL6011230 0.76 TSHR (0.58) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL29031730 0.76 TSHR (0.48) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL6570672 0.76 TSHR (0.58) IKBKBBRD4ADORA2AADORA1TSHR
SCHEMBL398678 0.75 ADORA2A (0.54) IKBKBBRD4ADORA2AADORA1TSHR
Hydrochloric Acid SCHEMBL6572095 0.74 TSHR (0.56) IKBKBBRD4ADORA2AADORA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424866-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS -SECRETASE INHIBITORS High Point Pharmaceuticals, LLC (US) 2012-03-07 EP disclosed